Canopy Partners »

AstraZeneca shares owned by Canopy Partners

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Canopy Partners from 13F filings

Historical chart of Canopy Partners investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Canopy Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Canopy Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $256k 3.8k 67.35

More positions owned by Canopy Partners

iShares Core MSCI EAFE ETF Etf (IEFA)
Spdr S&p 500 Etf Etf (SPY)
Apple Common Stock (AAPL)
Microsoft Common Stock (MSFT)
SPDR S&P Midcap 400 ETF Etf (MDY)
iShares Core MSCI Emerging ETF Etf (IEMG)
iShares Russell Mid Cap ETF Etf (IWR)
Alphabet Inc. Class A Common Stock (GOOGL)
Amazon.Com Common Stock (AMZN)
Vanguard Total Stock Market ETF Etf (VTI)
iShares Core S&P Small-Cap ETF Etf (IJR)
JPMorgan Chase Common Stock (JPM)
Meta Platforms Inc Class A Common Stock (META)
iShares Core S&P 500 ETF Etf (IVV)
UnitedHealth Group Common Stock (UNH)

View all positions for Canopy Partners

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
Jennison Associates
Sanders Capital
Goldman Sachs Group
Bank of America Corporation
Franklin Resources
Fisher Investments
Atlantic Trust
Dimensional Fund Advisors
Holocene Advisors
ClearBridge Advisors
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding AstraZeneca